Rui Li

11PUBLICATIONS

79CO-AUTHORS

Medical molecular engineering of nucleic acids and proteinsPrimary health careApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)HaematologyGene and molecular therapy

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (11)

Sort by Publication Date:

|Jul 03, 2026

Signaling Mutations Negate the Favorable Impact of NPM1 Mutations in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With VEN/HMA.

|Jun 25, 2026

Embedding a primary care provider in sickle cell teams improves sickle cell care.

|May 22, 2026

Clinical outcomes of CD3xCD20 bispecific antibodies in patients with central nervous system involvement by lymphoma.

|May 21, 2026

Clonal Hematopoiesis Rates in a Recurrent Venous Thrombosis Population: A Prospective Pilot Study.

|Feb 03, 2026

Clinical outcomes of older patients with NPM1-mutated or KMT2A-rearranged AML before menin inhibitors: a Beat AML report.

Joshua F Zeidner, Jayanshu Jain, Rina Li Welkie

|Jun 12, 2025

Azacitidine, Venetoclax, and Revumenib for Newly Diagnosed <i>NPM1</i>-Mutated or <i>KMT2A</i>-Rearranged AML.

Joshua F Zeidner, Tara L Lin, Rina Li Welkie

Pageof 2

Frequent Collaborators

Joshua F Zeidner

Tara L Lin

Alice S Mims

Elie Traer

Brian J Druker

Catherine Smith

Vu H Duong

Yazan F Madanat

Yazeed Sawalha

Narendranath Epperla

Frequent Collaborators

Joshua F Zeidner

Tara L Lin

Alice S Mims

Elie Traer